Bioventus (BVS) Finished Goods (2020 - 2026)

Bioventus has reported Finished Goods for 7 years, with the latest figure at $63.9 million in Q1 2026.

• For the quarter ending Q1 2026, Finished Goods fell 10.28% year-over-year to $63.9 million; the trailing twelve-month figure through Mar 2026 stood at $63.9 million (down 10.28% YoY), and the FY2025 full-year result was $61.0 million, down 13.33% from the prior year.
• Finished Goods for Q1 2026 stood at $63.9 million, up from $61.0 million in the prior quarter.
• The five-year high for Finished Goods was $75.0 million in Q3 2023, with the low at $51.7 million in Q2 2022.
• Historically, Finished Goods has averaged $66.5 million across 5 years, with a median of $66.6 million in 2024.
• Annual changes were most pronounced in 2022 — Finished Goods soared 75.2% — and 2025, when it retreated 13.33%.
• Bioventus' Finished Goods stood at $66.3 million in 2022, then increased by 5.97% to $70.3 million in 2023, then grew by 0.15% to $70.4 million in 2024, then slipped by 13.33% to $61.0 million in 2025, then rose by 4.74% to $63.9 million in 2026.
• The last three Finished Goods figures came in at $63.9 million (Q1 2026), $61.0 million (Q4 2025), and $74.4 million (Q3 2025), per Business Quant data.